6329-78-8

Basic information

• Product Name: N-(3-bromo-4-hydroxyphenyl)acetamide
• CAS NO: 6329-78-8
• Molecular Formula: C₈H₈BrNO₂
• Molecular Weight: 230.0586
• Mol File: 6329-78-8.mol
• Article Data: 7

Chemical Properties

• Boiling Point: 380.7°C at 760 mmHg
• Flash Point: 184.1°C
• Density: 1.677g/cm³
• Vapor Pressure: 2.44E-06mmHg at 25°C
• Refractive Index: 1.651
• CAS DataBase Reference: N-(3-bromo-4-hydroxyphenyl)acetamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-(3-bromo-4-hydroxyphenyl)acetamide(6329-78-8)
• EPA Substance Registry System: N-(3-bromo-4-hydroxyphenyl)acetamide(6329-78-8)

Safety Data

• Hazardous Substances Data: 6329-78-8(Hazardous Substances Data)

Upstream product

• 103-90-2 4-acetaminophenol 
• 95-56-7 2-hydroxybromobenzene 
• 5847-59-6 2-bromo-4-nitrophenol 
• 16750-67-7 4-amino-2-bromophenol 
• 108-24-7 acetic anhydride 

Downstream Products

• 1223466-37-2 N-(4-benzyloxy-3-bromophenyl)acetamide 
• 6943-73-3 N-(3-bromo-4-methoxyphenyl)acetamide 
• 1438868-24-6 (E)-2-bromo-4-(4-nitrostyryl)phenol 
• 92-52-4 biphenyl 
• 92-03-5 2-bromo-4-phenylphenol 
• 74568-53-9 (E)-methyl 3-(3-bromo-4-hydroxyphenyl)acrylate 
• 1313574-51-4 7-bromo-8-oxo-1,2,3,4-tetraphenylspiro[4.5]deca-1,3,6,9-tetraene 
• 1318802-67-3 C₁₅H₁₈N₄O₃ 
• 1318802-89-9 C₂₅H₂₉ClN₄O₅ 
• 1318802-88-8 C₂₆H₃₂N₄O₅ 

Relevant articles and documents

THERAPEUTIC AGENT FOR INFLAMMATORY DISEASES, AUTOIMMUNE DISEASES, FIBROTIC DISEASES, AND CANCER DISEASES

A therapeutic agent for treating at least one disease selected from the group consisting of inflammatory diseases, autoimmune diseases, fibrotic diseases, and cancer diseases, comprising: at least one selected from the group consisting of a compound represented by the following general formula (1) and pharmacologically acceptable salts thereof as an active ingredient. [In the formula (1), R1 and R2 may be the same or different and each represents a hydrogen atom, a halogen atom, a hydroxyl group, a carboxy group, a cyano group, an optionally substituted C1-6 alkyl group et al.; R3 represents a hydrogen atom; R4 represents an optionally substituted 4- to 10-membered monocyclic heterocyclic group containing 1 to 4 heteroatoms selected from an oxygen atom, a nitrogen atom, and a sulfur atom; X represents a group represented by the following formula: -CH2-, - CH2-CH2-, -CH2-CH2-CH2-, or -CH2-O-CH2-; and Z represents a hydrogen atom or a hydroxyl group.]

Derivatization of methylglyoxal for LC-ESI-MS analysis—stability and relative sensitivity of different derivatives

The great research interest in the quantification of reactive carbonyl compounds (RCCs), such as methylglyoxal (MGO) in biological and environmental samples, is reflected by the fact that several publications have described specific strategies to perform

Functionalized alkoxy arene diazonium salts from paracetamol

Arene diazonium tetrafluoroborates can be synthesized from aromatic acetamides via a sequence of deacetylation, diazotation and precipitation, induced by anion exchange. The reaction is conducted as a convenient one-flask transformation with consecutive addition of the appropriate reagents. Exchange of solvents or removal of byproducts prior to isolation of the product is not required. The arene diazonium salts are isolated from the reaction mixture by simple filtration. Two complementary protocols are presented, and the utility of the reaction is exemplified for a synthesis of the diarylheptanoid natural product de-O-methyl centrolobine.